#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17700	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2255	781.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1457	1457	C	1052	C	986	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32784	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3573	914.7	0	.	n	.	0	T695C	SNP	695	695	T	1033	1033	C	966	C,A	908,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32784	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3573	914.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1675	1675	A	1163	A	1075	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32784	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3573	914.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2309	2309	C	1071	C,A	989,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32784	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3573	914.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2935	2935	T	972	T,C	919,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32784	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3573	914.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2383	2383	A	1002	A	932	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2316	folP	852	852	100.0	folP.l15.c4.ctg.1	1586	145.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1060	1062	AGC	236;240;242	A,G;G;C	228,1;231;234	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5980	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3232	184.1	1	SNP	p	S91F	0	.	.	271	273	TCC	483	485	TCC	198;195;197	T;C;C	184;182;186	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5980	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3232	184.1	1	SNP	p	D95G	0	.	.	283	285	GAC	495	497	GAC	184;185;184	G;A;C	174;171;172	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5980	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3232	184.1	1	SNP	p	D95N	0	.	.	283	285	GAC	495	497	GAC	184;185;184	G;A;C	174;171;172	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1908	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1269	149.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	446	448	ACC	194;192;192	A;C;C	180;184;179	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1908	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1269	149.6	0	.	p	.	0	R44H	NONSYN	130	132	CGC	461	463	CAC	196;199;198	C;A;C	183;186;190	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1908	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1269	149.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	644	646	CAC	236;235;236	C;A;C	221;221;220	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1908	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1269	149.6	1	SNP	p	G45D	0	.	.	133	135	GGC	464	466	GGC	198;199;204	G;G;C	189;188;191	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1004	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1017	98.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6120	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	201.8	1	SNP	p	D86N	0	.	.	256	258	GAC	634	636	GAC	273;269;266	G;A;C	253;246;246	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6120	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	201.8	1	SNP	p	S87W	0	.	.	259	261	AGT	637	639	AGT	266;266;268	A;G;T	244;244;241	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6120	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	201.8	1	SNP	p	S87R	0	.	.	259	261	AGT	637	639	AGT	266;266;268	A;G;T	244;244;241	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6120	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	201.8	1	SNP	p	S87I	0	.	.	259	261	AGT	637	639	AGT	266;266;268	A;G;T	244;244;241	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6120	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3022	201.8	1	SNP	p	S88P	0	.	.	262	264	TCC	640	642	TCC	268;268;270	T;C;C	245;245;249	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5076	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2504	201.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1486	1488	GGC	218;217;216	G;G;C	200;195;196	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1253	1255	GCA	313;316;315	G;C;A	291;291;293	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1256	1258	ATC	316;314;314	A;T;C	293;293;292	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1268	1270	GTG	315;314;312	G;T;G	295;288;292	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1268	1270	GTG	315;314;312	G;T;G	295;288;292	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1772	1774	ACC	192;191;193	A;C;C	172;172;175	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1826	1828	GCG	175;174;173	G;C,T,A;G	154;144,2,1;150	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1826	1828	GCG	175;174;173	G;C,T,A;G	154;144,2,1;150	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1949	1951	GGC	194;194;192	G;G;C	174;172;173	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1958	1960	GGC	185;186;186	G;G;C,T	162;161;162,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2503	191.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1976	1978	CCG	163;165;163	C,G;C;G,A	116,3;122;119,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6470	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3106	207.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1638	1640	CTG	232;233;227	C;T;G	202;208;202	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2612	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1785	145.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	538	538	C	168	C	150	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3290	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1703	192.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1034	1034	T	284	T,A	264,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3290	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1703	192.5	1	SNP	p	G120K	0	.	.	358	360	GGT	761	763	GGT	255;258;258	G;G;T,G	246;246;244,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3290	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1703	192.5	1	SNP	p	A121D	0	.	.	361	363	GCC	764	766	GCC	264;261;261	G;C,T;C	252;251,1;252	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3290	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1703	192.5	1	SNP	p	A121N	0	.	.	361	363	GCC	764	766	GCC	264;261;261	G;C,T;C	252;251,1;252	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12774	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	4836	263.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1938	1940	AAT	287;291;291	A;A;T	274;278;278	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1454	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1042	139.1	1	SNP	p	V57M	1	.	.	169	171	ATG	514	516	ATG	311;316;318	A;T;G,A	280;287;288,2	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
